
A steady mega-cap compounder trading near fair value. Frameworks sharply disagree on it.
Mkt Cap
$295.92B
P/E
—
PEG
1.95
P/B
-29.57
Dividend
3.23%
ROE
—
About the business
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Who would buy PM?
Consensus 36/100 · Mixed · Investors are split.
Endorses
· 3 frameworksOperating Margin > 20% 36.0% clears "> 20.0%".
Operating Margin > 15% 36.0% clears "> 15.0%".
P/B < 1.5 -29.57× clears "< 1.50×".
6 insiders sold $28.8M on a discretionary basis. Discretionary selling carries more signal than planned disposals, but insiders sell for many non-thesis reasons (taxes, diversification, life events) — do not over-read it. Over the 6M window, insiders are net buyers by 184,029 shares.
In Prism's context
Insider selling on a mature quality name is often compensation-driven and should not over-rotate a thesis built on durable cash flows — though concentrated discretionary selling is always worth flagging.
| Insider | Role | Type | Date | Shares | Avg price | Value | Own |
|---|---|---|---|---|---|---|---|
| COMBES MICHEL | Director | Award / grant | May 6, 2026 | 1,119 | $169.93 | $190K | Direct |
| BOUGH BONIN | Director | Award / grant | May 6, 2026 | 1,119 | $169.93 | $190K | Direct |
| MORPARIA KALPANA | Director | Award / grant | May 6, 2026 | 1,119 | $169.93 | $190K | Direct |
| YANAI SHLOMO | Director | Award / grant | May 6, 2026 | 1,119 | $169.93 | $190K | Direct |
| POLET ROBERT | Director | Award / grant | May 6, 2026 | 1,119 | $169.93 | $190K | Direct |
| DOBROWOLSKI REGINALDO | Officer | Open-market sell | Feb 20, 2026 | 6,000 | $183.48 | $1.10M | — |
| KENNEDY STACEY | Officer | Open-market sell | Feb 20, 2026 | 14,350 | $183.13 | $2.63M | Direct |
| GUERIN YANN | Officer | Open-market sell | Feb 19, 2026 | 4,000 | $181.69 | $727K | Direct |
| BABEAU EMMANUEL | Officer | Open-market sell | Feb 19, 2026 | 33,800 | $181.61 | $6.14M | Direct |
| OLCZAK JACEK | Officer and Director | Open-market sell | Feb 19, 2026 | 80,000 | $182.18 | $14.57M | Direct |
| DE WILDE FREDERIC J | Officer | Open-market sell | Feb 19, 2026 | 20,000 | $182.58 | $3.65M | Direct |
| KENNEDY STACEY | Officer | Award / grant | Feb 6, 2026 | 16,210 | $47.26 | $766K | Direct |
| DOBROWOLSKI REGINALDO | Officer | Award / grant | Feb 6, 2026 | 6,538 | $71.41 | $467K | — |
| GUERIN YANN | Officer | Award / grant | Feb 6, 2026 | 8,280 | $105.47 | $873K | Direct |
| BABEAU EMMANUEL | Officer | Award / grant | Feb 6, 2026 | 61,386 | $31.95 | $1.96M | Direct |
| DE WILDE FREDERIC J | Officer | Award / grant | Feb 6, 2026 | 33,079 | $55.62 | $1.84M | Direct |
| OLCZAK JACEK | Officer and Director | Award / grant | Feb 6, 2026 | 171,039 | $33.83 | $5.79M | Direct |
| CALANTZOPOULOS ANDRE | Chairman of the Board | Award / grant | Feb 5, 2026 | 40,052 | $0.00 | $0 | Direct |
Insider activity from Yahoo Finance (quoteSummary: insiderTransactions + netSharePurchaseActivity). Cached 6 hours. · Insiders hold 0.2% of shares outstanding.
Net 6M: +184,029 sh
Price history
Drag across the chart to select a custom period — all analysis below refocuses to that window.
Add Philip Morris International Inc. at a hypothetical weight and Prism recalculates your whole book:
Sharpe, Sortino, volatility, max drawdown, beta — before and after.
How much this shifts your top sector weight and overall diversification.
Whether this leans your book more toward Quality, Value, Growth, Deep Value, Income, or Momentum.
Portfolio analytics are part of the member experience.
Sign in to run this simulationPM: 47% estimated probability of outperforming over the next 12M window. 1 of 6 signal families negative (medium confidence). Strongest support: 97% through 52w range. Main risk to monitor: 144% above fair value.
Probabilistic research output, not financial advice. Prism recommendations are based on available data, historical relationships, and model assumptions. They do not guarantee future returns. Conduct independent due diligence before any investment decision.
Backtested and similar-setup statistics may be affected by survivorship bias, look-ahead bias, overfitting, transaction costs, liquidity constraints, and data limitations. Probability estimates are anchored heuristics — not validated forecasts — until the walk-forward backtest pipeline is in place.
FCF yield 2.9%
144% above fair value
Indicative only. Probabilities are model-implied weights for stress-testing — not forecasts.
A turnaround takes hold: margin recovers toward peer averages, revenue stabilises, and the market re-prices the asset value rather than the running earnings.
No deterioration, no surprise re-acceleration. 36% operating margin and 9% top-line growth chug along; the multiple slowly converges to the central fair-value estimate.
Sector: Consumer Defensive. MENA-aware investors can sanity-check whether the US name is offering value relative to regional peers.
| Metric | PM | GCC median | MENA median | Global ex-US |
|---|---|---|---|---|
| P/E (TTM) | — | 18.0× | 15.0× | 17.0× |
| P/B | -29.57× | 3.50× | 2.80× | 3.20× |
| Dividend yield | 3.23% | 3.20% | 2.80% | 2.60% |
| ROE |
Reported EPS $1.96 vs $2.04 expected — a manageable miss. Whether it matters depends on cause: input-cost pressure or one-off charges shrug off; demand softness compounds. Trailing operating margin: 36.0%.
A miss without a clear one-off cause raises questions about the durability of the margin structure.
Decelerating growth + a miss is the pattern that resets multiples — even a small miss matters when the prior multiple was full.
Already cheap; the question is whether the deterioration is cyclical (digestible) or structural (avoid).
Next earnings
Wed, Jul 22 · consensus EPS $2.04 · last actual $1.96
P/E Ratio (TTM)
N/A
PEG Ratio
1.95
P/B Ratio
-29.57
EPS Growth
-9.3%
Revenue Growth
9.1%
Debt / Equity
N/A
Net Cash / Share
$-29.84
Return on Equity
N/A
Gross Margin
67.3%
Operating Margin
36.0%
FCF / Share
$5.50
Current Ratio
0.98
Rejects
· 3 frameworksPEG < 1 (growth at a discount) is 1.95× — fails "< 1.00×".
Revenue Growth > 15% is 9.1% — fails "> 15.0%".
FCF Yield > 7% is 2.9% — fails "> 7.0%".
Trades meaningfully above the fair-value range — limited margin of safety.
Quality is mixed — some strengths, some softness.
Leverage is high relative to coverage — balance-sheet risk on the table.
Price action is firm and trending higher.
Behavioural read is mixed — some accumulation, some distribution.
Recent miss and / or risk patterns weigh on the catalyst path.
Among 98 historical setups with similar Prism Score and signal-agreement profiles, 49% beat the benchmark over the next 12 months, with average excess return of -0.1% / yr.
Op margin 36% · Gross 67%
D/E — · CR 0.98
Net selling — 10 insiders
2 tracked holders · peak 10.1%
3.23% yield
97% through 52w range
EPS -9% · Rev 9%
Cyclical earnings prove to be at peak; revenue stalls and the multiple, already low, drifts lower as estimates re-rate down.
| — |
| 18.0% |
| 16.0% |
| 14.0% |
Institutional Own.
83.4%
Insider Own.
0.2%
Dividend Yield
3.23%
Book Value / Share
$-6.42
Superinvestor ownership
Held by 2 tracked superinvestors · peak weight 6.1%
Weights reflect each investor's latest 13F or factsheet snapshot. Data lags real time by 45+ days.